US Stock Market Closed

Dashboard

Tandem Diabetes Care, Inc. (TNDM)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

B

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

CEO

John F. Sheridan

Employees

1,043

Industry

Drug Delivery Devices

Sector

Healthcare

Headquarters

San Diego

Exchange

NASDAQ

Summary Stats

Market Cap

2.54B

Revenue

791M

Net Income

-67.9M

EPS

-$1.06

Price-to-Earnings

-37.3

Price-to-Book

6.03

Debt-to-Equity

1.48

News

Analyst Ratings

Price targets projected by 15 analysts

High

$140.00

Average

$129.13

Low

$99.00

Ratings calculated by 15 analysts

Buy

11

Hold

4

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.22

Actual

-$0.27 -440.0%

Consensus

-0.05

Report Date

Year Ago

0.09

Year Ago Change %

Down 400%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites